Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2003
11/26/2003EP1364649A1 Adduct of topiramate and tramadol hydrochioride and uses thereof
11/26/2003EP1364648A1 Cryptotanshinone for preventing and alleviating alzheimer's disease
11/26/2003EP1364069A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes
11/26/2003EP1364023A2 Method of diagnosing and treating cartilage disorders
11/26/2003EP1364014A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/26/2003EP1364002A2 Process for the preparation of neutrophil inhibitory factor
11/26/2003EP1363993A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I$g(k)B KINASE (IKK)
11/26/2003EP1363950A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors
11/26/2003EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof
11/26/2003EP1363920A1 Modified psma ligands and uses related thereto
11/26/2003EP1363914A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
11/26/2003EP1363913A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
11/26/2003EP1363912A1 Novel substituted imidazotriazinones
11/26/2003EP1363910A2 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
11/26/2003EP1363906A2 Heterocyclic inhibitors of erk2 and uses thereof
11/26/2003EP1363899A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363891A2 Anthrone derivatives and their use as jnk inhibitors
11/26/2003EP1363885A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363874A2 Tryptase inhibitors
11/26/2003EP1363702A1 Methods of inhibiting kinases
11/26/2003EP1363674A2 Agents and methods for treating pain
11/26/2003EP1363666A1 Methods for treating disease states comprising administration of low levels of antibodies
11/26/2003EP1363656A2 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system
11/26/2003EP1363652A2 Way to obtain an extract with antidepressant and opioid antagonists properties and pharmaceutical products obtained from it
11/26/2003EP1363651A1 Herbal compositions useful as chemopreventive and therapeutic agents
11/26/2003EP1363644A2 Modulation of gsk-3beta activity and its different uses
11/26/2003EP1363639A1 PYRROLO 2,3-d]PYRIMIDINE AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
11/26/2003EP1363638A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/26/2003EP1363635A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
11/26/2003EP1363634A2 Compounds for the treatment of addictive disorders
11/26/2003EP1363632A1 Receptor selective cannabimimetic aminoalkylindoles
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363630A2 Kappa opioid receptor ligands
11/26/2003EP1363629A1 Kappa opioid receptor ligands
11/26/2003EP1363624A2 Fluoro oxindole derivatives as modulators of kcnq potassium channels
11/26/2003EP1363619A2 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
11/26/2003EP1363618A1 Pharmaceutical composition for treating multiple sclerosis
11/26/2003EP1363608A1 Treatment of sleep disturbances
11/26/2003EP1363606A1 Use of gaba[a] inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators or vitamin e for the treatment of coginitive disorders
11/26/2003EP1363605A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
11/26/2003EP1363581A2 Pyrrolo(2,3-d)pyrimidine nucleoside analogs
11/26/2003EP1363508A1 Emulsions and aqueous dispersions of phytosterols
11/26/2003EP1268487B1 Tricyclic protein kinase inhibitors
11/26/2003EP1224471B1 Dpi-6, a therapeutic biomarker in neurological disorders
11/26/2003EP1214319B1 Imidazo-pyridine derivatives as ligands for gaba receptors
11/26/2003EP1204659B1 Serotonergic benzofurans
11/26/2003EP1140034B1 Controlled release formulation of divalproex sodium
11/26/2003EP1086706B1 Stabilized compositions containing nootropic drugs
11/26/2003EP1083902B1 Novel galenic formulations of meloxicam for oral administration
11/26/2003EP1025096B1 Substituted chroman derivatives
11/26/2003EP1025095B1 Substituted chroman derivatives
11/26/2003EP1015457B1 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors
11/26/2003EP1000046B1 Piperazine derivatives active on the lower urinary tract
11/26/2003EP0912601B1 Suppression of immune response via inhibition of cathepsin s
11/26/2003EP0814843B1 Hapten-carrier conjugates for use in drug-abuse therapy
11/26/2003EP0814813B1 Use of penciclovir for the treatment of human herpes-virus-8
11/26/2003EP0765326B1 Benzoylecgonine, ecgonine and ecgonidine derivatives
11/26/2003EP0708777B1 Abeo-ergoline derivatives as 5ht1a ligands
11/26/2003EP0605474B1 Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
11/26/2003CN1458979A Modulating multiple lineage kinase proteins
11/26/2003CN1458930A Tartrate salts of thiazolidinedione derivative
11/26/2003CN1458926A Nitric oxide donors based on metallic centres
11/26/2003CN1458853A Carbamate compounds for use in preventing or treating nearopathic pain and cluster and migraine headache-associated pain
11/26/2003CN1458845A Pharmaceutical composition comprising condensed indole compound
11/26/2003CN1458843A Aotomatic controlling nurve regulator and its health drinks and foods
11/26/2003CN1457902A Method for influencing sleep and relative activity to sleep
11/26/2003CN1457866A Quick-acting Chinese patent medicine for treating sleeplessness
11/26/2003CN1457864A Pill for treating pestilence, high fever and headache
11/26/2003CN1457863A Pill for treating apoplexy and hemiparalysis
11/26/2003CN1457845A Medicinal wine for curing old injury recurrent pain
11/26/2003CN1457843A Drug addiction stopping medicine for opium medicine addict
11/26/2003CN1457793A Use of ginsenoside in making medicine
11/26/2003CN1128800C Pyrolo [2,3-d] pyrimidine compounds and its composition and use
11/26/2003CN1128788C Benzyl(idene)-lactam derivatives, their prepn. and their use as selective(ant) agonists of 5-HT 1A and/or 5-HT 1D receptors
11/26/2003CN1128620C Use of levobupivacaine in preparing medicine for treating migraine
11/26/2003CN1128617C Preparation method for medicinal composition containing triazolyl derivative
11/25/2003US6653508 Use treating various medical conditions, including pain
11/25/2003US6653471 Tricyclic heteroaromatic compounds containing pyrrole ring; central nervous system disorder treatment; side effect reduction
11/25/2003US6653460 Voltage-gated calcium channel antagonist and method
11/25/2003US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same
11/25/2003US6653446 Nucleotide sequences which code enzymatic polypeptide for use in treatment of gout, kidney, blood and preferential genetic disorders
11/25/2003US6653347 For therapy
11/25/2003US6653344 Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for treatment of neurodegenerative disease
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653325 Dyskinesias, by administering a substituted phenylazacycloalkane and a dopamine agonist to the patient
11/25/2003US6653315 Substituted 5-amino-imidazolo-(4,3-e)-1,2,4-triazolo(1,5-c)-pyrimidines; central nervous system diseases; Parkinson's disease
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653303 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653134 Obtaining a bone marrow sample from a human, isolating stromal cells, and administering to the central nervous system of the patient; treating a genetic disease, a tumor, trauma and stroke
11/25/2003US6652864 Administering compound of nerve growth factor-enzymatically cleavable amide linker-viricide
11/25/2003US6652856 Method for the treatment of fibrosis
11/25/2003US6652855 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/25/2003US6652854 Administering agents that hinder CD30/CD30L (CD30L=ligand of CD30) binding; animal model of arthritis for drug screening
11/25/2003US6652479 Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments
1 ... 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 ... 1833